United-Guardian (NASDAQ:UG) Share Price Breaks Above Two Hundred Day Moving Average – Time to Sell?

United-Guardian, Inc. (NASDAQ:UG) shares passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $6.95 and traded as high as $7.07. United-Guardian shares last traded at $7.07, with a volume of 15,715 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of United-Guardian in a research report on Monday, October 19th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat, the company currently has an average rating of “Hold”.

United-Guardian Stock Up 6.2%

The firm has a 50 day moving average price of $7.05 and a 200 day moving average price of $6.95. The stock has a market capitalization of $32.45 million, a PE ratio of 13.09 and a beta of 0.95.

United-Guardian (NASDAQ:UG) last announced its earnings results on Friday, August 7th. The company reported $0.16 earnings per share (EPS) for the quarter. United-Guardian had a return on equity of 22.24% and a net margin of 22.01%. The company had revenue of $3.11 million for the quarter.

Hedge Funds Weigh In On United-Guardian

Large investors have recently bought and sold shares of the stock. United Capital Financial Advisors LLC bought a new stake in shares of United-Guardian in the 2nd quarter worth $143,000. BlackRock Inc. purchased a new stake in shares of United-Guardian in the second quarter valued at about $105,000. Finally, Gamco Investors INC. ET AL raised its holdings in shares of United-Guardian by 1.2% in the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock valued at $1,101,000 after purchasing an additional 1,888 shares during the last quarter. 23.16% of the stock is currently owned by institutional investors.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.